Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover - FierceBiotech Radio | Lyssna här | Poddtoppen.se
Fler avsnitt av Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover
Pricing drugs, selling hype and how we got here in the first place
2018-05-15 |
15 min
+
The FierceMadness drug name showdown and how do drugs get their zany names anyway?
2018-03-13 |
21 min
+
Back from the dead: FierceBiotech Radio at the Battle of the Biotech Bands
2017-10-31 |
9 min
+
GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster
2016-03-18 |
28 min
+
The FDA's new boss, Sanofi's latest shortcut, and a little 'financial innovation'
2016-02-26 |
41 min
+
Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals
2016-02-18 |
39 min
+
Pharma's day on the Hill, biotech's paucity of M&A, and the gathering storm of biosimilars
2016-02-11 |
40 min
+
Gilead's wide-open future, biotech's long winter, and Sanofi's ongoing makeover
2016-02-04 |
36 min
+
Shire's byzantine Baxalta pursuit, biotech's pragmatic winter and Valeant's CEO shakeup
2016-01-08 |
22 min
+
The burning hole in Gilead's $25B pocket and AbbVie's future in hematology
2015-12-10 |
19 min
+
Podden och tillhörande omslagsbild på den här sidan tillhör
. Innehållet i podden är skapat av och inte av,
eller tillsammans med, Poddtoppen.
En ny version av sidan finns tillgänglig.
Ladda om
Stäng
